Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // June 2nd, 2008 // 6:49 am
Welcome to the working week. We hope you had an enjoyable, or at least interesting, weekend. The ASCO meeting, which will wind down tomorrow, generated some notable headlines and a few more developments can be found below. Call this an ASCO round-up. So as you prepare for meetings and deadlines, dig in…
New Hope For Astra-Zeneca’s Iressa? (BusinessWeek)
Celebrex May Hold Promise In Preventing Lung Cancer (Yahoo/Reuters)
ImClone’s Erbitux Seen As Limited Threat To Avastin (Bloomberg News)
Test May Predict Cancer Response To Anemia Meds (Yahoo/Reuters)